Major determinants of height development in Turner syndrome (TS) patients treated with GH: Analysis of 987 patients from KIGS

Pediatric Research

Volumn 61, Issue 1, 2007, Pages 105-110

  Ranke, Michael B ^a,j   Lindberg, Anders ^b   Longás, Angel Ferrández ^c   Darendeliler, Feyza ^d   Albertsson Wikland, Kerstin ^e   Dunger, David ^f   Cutfield, Wayne S ^g   Tauber, Maïthé ^h   Wilton, Patrick ^b   Wollmann, Hartmut A ^b   Reiter, Edward O ⁱ  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PFIZER INC   (United States)

^c HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^d ISTANBUL UNIVERSITY   (Turkey)

^e QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

^h Hospitalier Universitoire   (France)

ⁱ TUFTS UNIVERSITY   (United States)

^j UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CORRELATION ANALYSIS; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TURNER SYNDROME; CHILD; DRUG EFFECT; FEMALE;

ADOLESCENT; BODY HEIGHT; CHILD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; TURNER SYNDROME;

EID: 33846942666     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000250039.42000.c9     Document Type: Article

References (29)

1. Ranke MB, Saenger P 2001 Turner's syndrome. Lancet 358:309-314
2. Ranke MB, Grauer ML 1994 Adult height in Turner syndrome: results of a multinational survey 1993. Horm Res 42:90-94
3. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA 1997 Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54-63
4. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, Hultcrantz M, Landin-Wilhelmsen K, Lin A, Lippe B, Pasquino AM, Ranke MB, Rosenfeld R, Silberbach M 2001 Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 86:3061-3069
5. van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop S 2003 Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab 88:1119-1125
6. Growth Hormone Research Society 2001 Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 86:1868-1870
7. Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LT, Cutler GB Jr, 2005 Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab 90:5188-5196.
8. Jenkins PJ, Mukherjee A, Shalet SM 2006 Does growth hormone cause cancer? Clin Endocrinol (Oxf) 64:115-121
9. Cave CB, Bryant J, Milne R 2003 Recombinant growth hormone in children and adolescents with Turner syndrome. Cochrane Database Syst Rev 3:CD003887
10. Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA 2000 Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study. J Clin Endocrinol Metab 85:4212-4218
11. Tanner JM, Whitehouse RH, Takaishi M 1966 Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child 41:613-635
12. Ranke MB, Price DA, Albertsson-Wikland KA, Maes M, Lindberg A 1997 Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency - Analysis of 195 patients of the Kabi Pharmacia International Growth Study. Horm Res 48:62-71
13. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA 1995 Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24
14. Ranke MB, Stubbe P, Majewski F, Bierich JR 1988 Spontaneous growth in Turner's syndrome. Acta Paediatr Scand Suppl 343:22-30
15. Lyon AJ, Preece MA, Grant DB 1985 Growth curve for girls with Turner syndrome. Arch Dis Child 60:932-935
16. Niklasson A, Ericson A, Fryer JG, Karlberg J, Lawrence C, Karlberg P 1991 An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand 80:756-762
17. Ranke MB 1996 Towards a consensus on the definition of idiopathic short stature. Horm Res 45:64-66
18. Greulich WW, Pyle SI. 1952 Radiographic atlas of the skeletal development of the hand and wrist. University Press: Stanford, CA
19. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ 1998 Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 132:319-324
20. Stephure DK 2005 Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 90:3360-3366
21. Harris M, Hofman PL, Cutfield WS 2004 Growth hormone treatment in children: review of safety and efficacy. Paediatr Drugs 6:93-106
22. Ranke MB, Partsch CJ, Lindberg A, Dorr HG, Bettendorf M, Hauffa BP, Schwarz HP, Mehls O, Sander S, Stahnke N, Steinkamp H, Said E, Sippell W 2002 Adult height after GH therapy in 188 Ullrich-Turner syndrome patients: results of the German IGLU Follow-up Study 2001. Eur J Endocrinol 147:625-633
23. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ 2002 Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 87:2033-2041
24. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J 2000 Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab 85:2439-2445
25. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J 2000 High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 85:3653-3660
26. Ranke MB, Lindberg A, Martin DD, Bakker B, Wilton P, Albertsson-Wikland K, Cowell CT, Price DA, Reiter EO 2003 The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose. J Clin Endocrinol Metab 88:4748-4753
27. Soriano-Guillen L, Coste J, Ecosse E, Léger J, Tauber M, Cabrol S, Nicolino M, Brauner R, Chaussain J-L, Carel J-C 2005 Adult height and pubertal growth in Turner syndrome after treatment with recombinant growth hormone. J Clin Endocrinol Metab 90:5197-5204
28. Binder G, Baur F, Schweizer R, Ranke MB 2006 The d3 growth hormone receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short SGA children. J Clin Endocrinol Metab 91:659-664
29. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724